NCT02306161-D3
Dataset Information
Dataset ID: NCT02306161-D3
PubMed ID (PMID):
Publication Title:
Randomized Phase 3 Trial of Ganitumab Added to Interval Compressed Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma: A Report from the Children’s Oncology Group
Description of Dataset:
D3: There are 5 datasets associated with the PMID 36669140: NCT02306161-D1 through NCT02306161-D5. This dataset, NCT02306161-D3, provides the information for supplemental table A5: ganitumab serum concentrations for the first ten patients with metastatic Ewing sarcoma. There is one row per patient and time point where a serum ganitumab concentration was measured with result.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02306161 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®